lactic acid has been researched along with Shock, Cardiogenic in 103 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Background Lactic acidosis is associated with mortality in patients with cardiogenic shock (CS)." | 8.12 | Association Between the Acidemia, Lactic Acidosis, and Shock Severity With Outcomes in Patients With Cardiogenic Shock. ( Barsness, GW; Blankenberg, S; Holmes, DR; Jentzer, JC; Kashani, KB; Kirchhof, P; Patel, PC; Schrage, B; Westermann, D, 2022) |
| "Five patients with acute myocardial infarction and shock were treated with a new, highly selective beta-1-adrenoreceptor agonist, prenalterol." | 7.66 | Hemodynamic and cardiometabolic effects of prenalterol in patients with acute myocardial infarction and shock. ( Friedman, A; Häggmark, S; Reiz, S, 1981) |
| "Background Lactic acidosis is associated with mortality in patients with cardiogenic shock (CS)." | 4.12 | Association Between the Acidemia, Lactic Acidosis, and Shock Severity With Outcomes in Patients With Cardiogenic Shock. ( Barsness, GW; Blankenberg, S; Holmes, DR; Jentzer, JC; Kashani, KB; Kirchhof, P; Patel, PC; Schrage, B; Westermann, D, 2022) |
| " High lactic acid levels at 24 hours after ECMO, MODS and gastrointestinal bleeding are predictors of in-hospital mortality in adult patients, and appropriate control of blood sugar was beneficial for the recovery of patients." | 3.81 | [Outcome of extracorporeal membrane oxygenation support for adult patients in Fuwai Hospital during the last 10 years: treatment strategy and risk factors]. ( Bingyan, J; Cun, L; Feilong, H; Guodong, G; Jinxiao, H; Kun, Y; Lin, L; Qiang, H, 2015) |
| "The purpose of this study was to examine the use of lactic acid levels and continuous central venous oxygen saturation (central venous oximetry) to stratify and treat patients with acutely decompensated end-stage chronic congestive heart failure (CHF) presenting to the emergency department." | 3.70 | Undetected cardiogenic shock in patients with congestive heart failure presenting to the emergency department. ( Ander, DS; Gryzbowski, M; Jaggi, M; Levine, AB; Levine, TB; Masura, J; Rady, MY; Rivers, E, 1998) |
| "Sixty consecutive adult patients who developed septic shock and lactic acidosis requiring the administration of vasopressors." | 3.70 | Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock. ( Bollaert, PE; Gelot, AM; Larcan, A; Levy, B; Nabet, P; Sadoune, LO, 2000) |
| "Five patients with acute myocardial infarction and shock were treated with a new, highly selective beta-1-adrenoreceptor agonist, prenalterol." | 3.66 | Hemodynamic and cardiometabolic effects of prenalterol in patients with acute myocardial infarction and shock. ( Friedman, A; Häggmark, S; Reiz, S, 1981) |
| "We recommend lactate measurement in STEMI-subjects, especially when signs of compromised hemodynamics are present." | 2.90 | Lactate is a Prognostic Factor in Patients Admitted With Suspected ST-Elevation Myocardial Infarction. ( Bang, LE; Frikke-Schmidt, R; Frydland, M; Goetze, JP; Hansen, R; Hassager, C; Henriques, JPS; Holmvang, L; Jensen, LO; Kjaergaard, J; Lindholm, MG; Møller, JE; Møller-Helgestad, OK; Obling, L; Ouweneel, DM; Ravn, HB; Thomsen, JH; Udesen, NLJ; Wiberg, S, 2019) |
| "Cardiogenic shock is difficult to diagnose due to diverse presentations, overlap with other shock states (i." | 2.66 | Identifying cardiogenic shock in the emergency department. ( Daly, M; Koyfman, A; Lentz, S; Long, B, 2020) |
| "Although cardiogenic shock is uncommon in the emergency department, it is associated with high mortality." | 2.61 | Nonischemic Causes of Cardiogenic Shock. ( Wilcox, SR, 2019) |
| "The prognosis of cardiogenic shock is still dismal despite advancements in diagnostic and therapeutic options." | 2.46 | [Evaluation of microcirculation in cardiogenic shock]. ( Ferrari, M; Figulla, HR; Fritzenwanger, M; Jung, C; Lauten, A, 2010) |
| "In the multivariate Cox model analysis, cardiac arrest prior to ECMO initiation (adjusted HR 2." | 1.91 | Clinical outcome and risk factors for acute fulminant myocarditis supported by venoarterial extracorporeal membrane oxygenation: An analysis of nationwide CSECLS database in China. ( Chen, C; Du, Z; Guo, F; Hao, T; Hou, X; Huang, Y; Jiang, Y; Li, C; Liu, L; Liu, S; Pan, C; Qiu, H; Wu, C; Xie, H; Xie, J; Yang, Y, 2023) |
| "Sepsis is a dreaded complication in patients with postcardiotomy cardiogenic shock, especially ECMO-associated sepsis." | 1.91 | ( Abdullatif, MT; Aboughanima, MA; Albabtain, MA; AlBarak, MM; Arafat, AA; Azar, B; Belghith, M; Elshoura, YA; Gross, I; Hashavya, S; Ohana Sarna Cahan, L; Osman, AA; Reif, S; Tantway, TM, 2023) |
| "Severe Acidosis was present in 35." | 1.72 | Laboratory Markers of Acidosis and Mortality in Cardiogenic Shock: Developing a Definition of Hemometabolic Shock. ( Baran, DA; Barsness, GW; Henry, TD; Jentzer, JC; Kashani, KB; Patel, PC; Van Diepen, S; Wiley, BM, 2022) |
| "Hypotension was defined as systolic blood pressure <90 mm Hg or mean arterial pressure <60 mm Hg, and hypoperfusion as admission lactate >2 mmol/L, oliguria, or rising creatinine." | 1.62 | Defining Shock and Preshock for Mortality Risk Stratification in Cardiac Intensive Care Unit Patients. ( Baran, DA; Barsness, GW; Bell, MR; Burstein, B; Henry, TD; Holmes, DR; Jentzer, JC; Menon, V; Murphy, J; Naidu, SS; Rihal, CS; Van Diepen, S, 2021) |
| "Acute myocardial infarction is the most common cause of cardiogenic shock." | 1.48 | Predicting Survival in Patients Treated With Extracorporeal Membrane Oxygenation After Myocardial Infarction. ( Brehm, CE; Foy, AJ; Pabst, D; Peterson, B; Soleimani, B, 2018) |
| "It has higher predictive efficacy in septic shock, especially for 28-day prognosis." | 1.46 | Clinical study of a new Modified Early Warning System scoring system for rapidly evaluating shock in adults. ( Cao, Y; Qin, Q; Xia, Y, 2017) |
| "Hemolysis is common in all extracorporeal circuits as evident by the elevated plasma free hemoglobin (PFHb) level." | 1.42 | Plasma Free Hemoglobin Is an Independent Predictor of Mortality among Patients on Extracorporeal Membrane Oxygenation Support. ( Caldeira, C; Camporesi, EM; Mangar, D; Mirsaeidi, M; Omar, HR; Socias, S; Sprenker, C, 2015) |
| "Therapy refractory cardiogenic shock is associated with dismal outcome." | 1.40 | Percutaneous extracorporeal life support for patients in therapy refractory cardiogenic shock: initial results of an interdisciplinary team. ( Born, F; Fischer, M; Guenther, S; Hagl, C; Khaladj, N; Massberg, S; Peterss, S; Pichlmaier, M; Sattler, S; Theiss, HD, 2014) |
| "Only 65% of patients with septic shock had hyperlactataemia at the onset of shock and 76% of these also had a high lactate/pyruvate ratio." | 1.38 | Lactate/pyruvate ratio as a marker of tissue hypoxia in circulatory and septic shock. ( Bruzzi de Carvahlo, F; Cotton, F; De Backer, D; Orellano-Jimenez, C; Rimachi, R; Vincent, JL, 2012) |
| "Acute cardiogenic shock or cardiac arrest (CS/CA) before cardiopulmonary bypass (CPB) installation are life-threatening events in acute coronary syndromes." | 1.35 | Continuous coronary sinus perfusion reverses ongoing myocardial damage in acute ischemia. ( Costanzo, FS; Cristodoro, L; Onorati, F; Renzulli, A; Santarpino, G; Scalas, C, 2009) |
| "Seven patients with severe sepsis or septic shock, seven patients with cardiogenic shock, and seven healthy volunteers." | 1.33 | Lactate and glucose metabolism in severe sepsis and cardiogenic shock. ( Berger, MM; Bollmann, M; Cayeux, MC; Chioléro, RL; Martinez, A; Revelly, JP; Tappy, L, 2005) |
| "Standard criteria were used to diagnose septic shock." | 1.32 | Diagnostic and prognostic value of procalcitonin in patients with septic shock. ( Clec'h, C; Cohen, Y; Cupa, M; Ferriere, F; Fosse, JP; Hoang, P; Karoubi, P, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (4.85) | 18.7374 |
| 1990's | 10 (9.71) | 18.2507 |
| 2000's | 10 (9.71) | 29.6817 |
| 2010's | 43 (41.75) | 24.3611 |
| 2020's | 35 (33.98) | 2.80 |
| Authors | Studies |
|---|---|
| Duburcq, T | 1 |
| Goutay, J | 1 |
| Preau, S | 1 |
| Mugnier, A | 1 |
| Rousse, N | 1 |
| Moussa, MD | 1 |
| Vincentelli, A | 1 |
| Cuny, J | 1 |
| Parmentier-Decrucq, E | 1 |
| Poissy, J | 1 |
| Marbach, JA | 2 |
| Stone, S | 1 |
| Schwartz, B | 1 |
| Pahuja, M | 1 |
| Thayer, KL | 2 |
| Faugno, AJ | 1 |
| Chweich, H | 1 |
| Rabinowitz, JB | 1 |
| Kapur, NK | 3 |
| Martínez-Solano, J | 1 |
| Sousa-Casasnovas, I | 1 |
| Bellón-Cano, JM | 1 |
| García-Carreño, J | 1 |
| Juárez-Fernández, M | 1 |
| Díez-Delhoyo, F | 1 |
| Sanz-Ruiz, R | 1 |
| Devesa-Cordero, C | 1 |
| Elízaga-Corrales, J | 1 |
| Fernández-Avilés, F | 1 |
| Martínez-Sellés, M | 1 |
| Tindale, A | 1 |
| Vela, MM | 1 |
| Panoulas, V | 1 |
| Hillerson, D | 1 |
| Whiteside, HL | 1 |
| Dugan, AJ | 1 |
| Coots, RD | 1 |
| Tribble, TA | 1 |
| Abdel-Latif, A | 1 |
| Ogunbayo, GO | 1 |
| Duncan, MS | 1 |
| Gupta, VA | 1 |
| Di Santo, P | 1 |
| Simard, T | 1 |
| Jung, RG | 1 |
| Parlow, S | 1 |
| Abdel-Razek, O | 1 |
| Fernando, SM | 1 |
| Labinaz, M | 1 |
| Froeschl, M | 1 |
| Mathew, R | 1 |
| Hibbert, B | 1 |
| Jentzer, JC | 4 |
| Schrage, B | 2 |
| Patel, PC | 2 |
| Kashani, KB | 3 |
| Barsness, GW | 3 |
| Holmes, DR | 2 |
| Blankenberg, S | 2 |
| Kirchhof, P | 2 |
| Westermann, D | 2 |
| Hao, T | 1 |
| Jiang, Y | 1 |
| Wu, C | 1 |
| Li, C | 1 |
| Chen, C | 1 |
| Xie, J | 1 |
| Pan, C | 1 |
| Guo, F | 1 |
| Huang, Y | 1 |
| Liu, L | 1 |
| Xie, H | 1 |
| Du, Z | 1 |
| Hou, X | 1 |
| Liu, S | 1 |
| Yang, Y | 1 |
| Qiu, H | 1 |
| Lu, T | 1 |
| Tan, L | 1 |
| Xu, K | 1 |
| Liu, J | 1 |
| Liu, C | 1 |
| Zhang, G | 1 |
| Shi, R | 1 |
| Huang, Z | 1 |
| Montero, S | 1 |
| Rivas-Lasarte, M | 1 |
| Huang, F | 1 |
| Chommeloux, J | 1 |
| Demondion, P | 1 |
| Bréchot, N | 1 |
| Hékimian, G | 1 |
| Franchineau, G | 1 |
| Persichini, R | 1 |
| Luyt, CÉ | 1 |
| Garcia-Garcia, C | 1 |
| Bayes-Genis, A | 1 |
| Lebreton, G | 1 |
| Cinca, J | 1 |
| Leprince, P | 1 |
| Combes, A | 1 |
| Alvarez-Garcia, J | 1 |
| Schmidt, M | 1 |
| Tantway, TM | 1 |
| Arafat, AA | 1 |
| Albabtain, MA | 1 |
| Belghith, M | 1 |
| Osman, AA | 1 |
| Aboughanima, MA | 1 |
| Abdullatif, MT | 1 |
| Elshoura, YA | 1 |
| AlBarak, MM | 1 |
| Azar, B | 1 |
| Hashavya, S | 1 |
| Ohana Sarna Cahan, L | 1 |
| Reif, S | 1 |
| Gross, I | 1 |
| Sundermeyer, J | 1 |
| Dabboura, S | 1 |
| Weimann, J | 1 |
| Beer, BN | 1 |
| Becher, PM | 1 |
| Seiffert, M | 1 |
| Scolari, FL | 2 |
| Schneider, D | 2 |
| Fogazzi, DV | 2 |
| Gus, M | 2 |
| Rover, MM | 2 |
| Bonatto, MG | 2 |
| de Araújo, GN | 2 |
| Zimerman, A | 2 |
| Sganzerla, D | 2 |
| Goldraich, LA | 2 |
| Teixeira, C | 2 |
| Friedman, G | 2 |
| Polanczyk, CA | 2 |
| Rohde, LE | 2 |
| Rosa, RG | 2 |
| Wainstein, RV | 2 |
| Kurniawati, ER | 1 |
| Weerwind, PW | 1 |
| Maessen, JG | 1 |
| Basir, MB | 1 |
| Lemor, A | 1 |
| Gorgis, S | 1 |
| Patel, KC | 1 |
| Kolski, BC | 1 |
| Bharadwaj, AS | 1 |
| Todd, JW | 1 |
| Tehrani, BN | 1 |
| Truesdell, AG | 1 |
| Lasorda, DM | 1 |
| Lalonde, TA | 1 |
| Kaki, A | 1 |
| Schrieber, TL | 1 |
| Patel, NC | 1 |
| Senter, SR | 1 |
| Gelormini, JL | 1 |
| Marso, SP | 1 |
| Rahman, AM | 1 |
| Federici, RE | 1 |
| Wilkins, CE | 1 |
| Thomas McRae, A | 1 |
| Nsair, A | 1 |
| Caputo, CP | 1 |
| Khuddus, MA | 1 |
| Chahin, JJ | 1 |
| Dupont, AG | 1 |
| Goldsweig, AM | 1 |
| Lim, MJ | 1 |
| Wohns, DHW | 1 |
| Zhou, Y | 1 |
| Hacala, MJ | 1 |
| O'Neill, WW | 1 |
| Tabi, M | 1 |
| Burstein, BJ | 1 |
| Ahmed, A | 1 |
| Dezfulian, C | 1 |
| Fuernau, G | 6 |
| Desch, S | 3 |
| de Waha-Thiele, S | 2 |
| Eitel, I | 3 |
| Neumann, FJ | 1 |
| Hennersdorf, M | 2 |
| Felix, SB | 2 |
| Fach, A | 1 |
| Böhm, M | 2 |
| Pöss, J | 3 |
| Jung, C | 4 |
| Ouarrak, T | 1 |
| Schneider, S | 1 |
| Werdan, K | 1 |
| Zeymer, U | 3 |
| Thiele, H | 8 |
| Rossini, R | 1 |
| Ferlini, M | 1 |
| Daly, M | 1 |
| Long, B | 1 |
| Koyfman, A | 1 |
| Lentz, S | 1 |
| Nakamura, M | 1 |
| Imamura, T | 1 |
| Levitt, DG | 1 |
| Levitt, JE | 1 |
| Levitt, MD | 1 |
| Jones, DM | 1 |
| Ahmad, M | 1 |
| Burstein, B | 1 |
| Van Diepen, S | 2 |
| Murphy, J | 1 |
| Bell, MR | 1 |
| Henry, TD | 2 |
| Menon, V | 1 |
| Rihal, CS | 1 |
| Naidu, SS | 1 |
| Baran, DA | 2 |
| Gao, S | 1 |
| Liu, G | 1 |
| Yan, S | 1 |
| Lou, S | 1 |
| Gao, G | 1 |
| Hu, Q | 1 |
| Zhang, Q | 1 |
| Qi, J | 1 |
| Yan, W | 1 |
| Wang, Q | 1 |
| Wang, J | 1 |
| Ji, B | 1 |
| Abdullah, KQA | 1 |
| Roedler, JV | 1 |
| Vom Dahl, J | 2 |
| Szendey, I | 1 |
| Haake, H | 1 |
| Eckardt, L | 1 |
| Topf, A | 1 |
| Ohnewein, B | 1 |
| Jirak, P | 1 |
| Motloch, LJ | 1 |
| Wernly, B | 2 |
| Larbig, R | 1 |
| Ceglarek, U | 1 |
| Schellong, P | 1 |
| Rosolowski, M | 1 |
| Scholz, M | 1 |
| Willenberg, A | 1 |
| Kratzsch, J | 1 |
| Büttner, P | 1 |
| Jobs, A | 1 |
| Freund, A | 1 |
| Feistritzer, HJ | 1 |
| Isermann, B | 1 |
| Thiery, J | 1 |
| Omar, HR | 2 |
| Handshoe, JW | 1 |
| Tribble, T | 1 |
| Guglin, M | 1 |
| Wiley, BM | 1 |
| Borgel, D | 1 |
| Chocron, R | 1 |
| Grimaud, M | 1 |
| Philippe, A | 1 |
| Chareyre, J | 1 |
| Brakta, C | 1 |
| Lasne, D | 1 |
| Bonnet, D | 1 |
| Toubiana, J | 1 |
| Angoulvant, F | 1 |
| Desvages, M | 1 |
| Renolleau, S | 1 |
| Smadja, DM | 1 |
| Oualha, M | 1 |
| Ratcovich, HL | 1 |
| Josiassen, J | 1 |
| Helgestad, OKL | 1 |
| Linde, L | 1 |
| Jensen, LO | 3 |
| Ravn, HB | 2 |
| Joshi, FR | 1 |
| Engstrøm, T | 2 |
| Schmidt, H | 2 |
| Hassager, C | 4 |
| Møller, JE | 4 |
| Holmvang, L | 3 |
| Slottosch, I | 1 |
| Liakopoulos, O | 1 |
| Kuhn, E | 1 |
| Scherner, M | 1 |
| Deppe, AC | 1 |
| Sabashnikov, A | 1 |
| Mader, N | 1 |
| Choi, YH | 1 |
| Wippermann, J | 1 |
| Wahlers, T | 1 |
| Gjesdal, G | 1 |
| Braun, OÖ | 1 |
| Smith, JG | 1 |
| Scherstén, F | 1 |
| Tydén, P | 1 |
| Pabst, D | 1 |
| Foy, AJ | 1 |
| Peterson, B | 1 |
| Soleimani, B | 1 |
| Brehm, CE | 1 |
| Kubiak, GM | 1 |
| Tomasik, AR | 1 |
| Bartus, K | 1 |
| Olszanecki, R | 1 |
| Ceranowicz, P | 1 |
| Frydland, M | 1 |
| Wiberg, S | 1 |
| Lindholm, MG | 4 |
| Hansen, R | 1 |
| Henriques, JPS | 1 |
| Møller-Helgestad, OK | 1 |
| Bang, LE | 1 |
| Frikke-Schmidt, R | 1 |
| Goetze, JP | 1 |
| Udesen, NLJ | 1 |
| Thomsen, JH | 1 |
| Ouweneel, DM | 1 |
| Obling, L | 1 |
| Kjaergaard, J | 2 |
| Mungan, İ | 1 |
| Kazancı, D | 1 |
| Bektaş, Ş | 1 |
| Ademoglu, D | 1 |
| Turan, S | 1 |
| Ariza-Solé, A | 1 |
| Sánchez-Salado, JC | 1 |
| Sbraga, F | 1 |
| Ortiz, D | 1 |
| González-Costello, J | 1 |
| Blasco-Lucas, A | 1 |
| Alegre, O | 1 |
| Toral, D | 1 |
| Lorente, V | 1 |
| Santafosta, E | 1 |
| Toscano, J | 1 |
| Izquierdo, A | 1 |
| Miralles, A | 1 |
| Cequier, Á | 1 |
| Yang, L | 2 |
| Fan, Y | 2 |
| Lin, R | 2 |
| He, W | 2 |
| Fux, T | 1 |
| Holm, M | 1 |
| van der Linden, J | 1 |
| Bozbuga, N | 1 |
| Ye, L | 1 |
| Zong, Q | 1 |
| Zhao, W | 1 |
| Hongisto, M | 1 |
| Lassus, J | 1 |
| Spinar, J | 1 |
| Parissis, J | 1 |
| Banaszewski, M | 1 |
| Silva-Cardoso, J | 1 |
| Carubelli, V | 1 |
| Salvatore, D | 1 |
| Sionis, A | 1 |
| Mebazaa, A | 2 |
| Veli-Pekka, H | 1 |
| Kober, L | 1 |
| Masyuk, M | 1 |
| Abel, P | 1 |
| Hug, M | 1 |
| Haneya, A | 1 |
| Sack, S | 1 |
| Sideris, K | 1 |
| Langwieser, N | 1 |
| Graf, T | 1 |
| Franz, M | 1 |
| Westenfeld, R | 1 |
| Kelm, M | 1 |
| Udesen, NJ | 1 |
| Eiskjær, H | 1 |
| Schäfer, A | 1 |
| Werner, N | 1 |
| Terkelsen, CJ | 1 |
| Junker, A | 1 |
| Wachtell, K | 1 |
| Wilcox, SR | 1 |
| Rohm, CL | 1 |
| Gadidov, B | 1 |
| Leitson, M | 1 |
| Ray, HE | 1 |
| Prasad, R | 1 |
| Ge, M | 1 |
| Pan, T | 1 |
| Wang, JX | 1 |
| Chen, ZJ | 1 |
| Wang, DJ | 1 |
| Hajjar, LA | 1 |
| Almeida, JP | 1 |
| Fukushima, JT | 1 |
| Rhodes, A | 1 |
| Vincent, JL | 2 |
| Osawa, EA | 1 |
| Galas, FR | 1 |
| Pelletier, JS | 1 |
| LaBossiere, J | 1 |
| Dicken, B | 1 |
| Gill, RS | 1 |
| Sergi, C | 1 |
| Tahbaz, N | 1 |
| Bigam, D | 1 |
| Cheung, PY | 1 |
| Guenther, S | 1 |
| Theiss, HD | 1 |
| Fischer, M | 1 |
| Sattler, S | 1 |
| Peterss, S | 1 |
| Born, F | 1 |
| Pichlmaier, M | 1 |
| Massberg, S | 1 |
| Hagl, C | 1 |
| Khaladj, N | 1 |
| Park, TK | 1 |
| Yang, JH | 1 |
| Choi, SH | 1 |
| Song, YB | 1 |
| Hahn, JY | 1 |
| Choi, JH | 1 |
| Sung, K | 1 |
| Lee, YT | 1 |
| Gwon, HC | 1 |
| Loforte, A | 3 |
| Marinelli, G | 2 |
| Musumeci, F | 2 |
| Folesani, G | 2 |
| Pilato, E | 2 |
| Martin Suarez, S | 2 |
| Montalto, A | 2 |
| Lilla Della Monica, P | 1 |
| Grigioni, F | 2 |
| Frascaroli, G | 2 |
| Menichetti, A | 2 |
| Di Bartolomeo, R | 2 |
| Arpesella, G | 1 |
| Fröhlich, G | 1 |
| Pibernik, A | 1 |
| Ferrari, M | 2 |
| Jafrancesco, G | 1 |
| Castrovinci, S | 1 |
| Cefarelli, M | 1 |
| Potena, L | 1 |
| Magnani, G | 1 |
| Caramelli, F | 1 |
| Pappalardo, F | 1 |
| Ostenfeld, S | 1 |
| Bro-Jeppesen, J | 1 |
| Wanscher, M | 1 |
| Kriechbaum, S | 1 |
| Ewen, S | 1 |
| Graf, J | 2 |
| Häger, I | 1 |
| Petros, S | 1 |
| Link, A | 1 |
| Laufs, U | 1 |
| Li, CL | 1 |
| Wang, H | 1 |
| Jia, M | 1 |
| Ma, N | 1 |
| Meng, X | 1 |
| Hou, XT | 1 |
| Haft, JW | 1 |
| Casassus, F | 1 |
| Corre, J | 1 |
| Leroux, L | 1 |
| Chevalereau, P | 1 |
| Fresselinat, A | 1 |
| Seguy, B | 1 |
| Calderon, J | 1 |
| Coste, P | 1 |
| Ouattara, A | 1 |
| Roques, X | 1 |
| Barandon, L | 1 |
| de Waha, S | 1 |
| Schuler, G | 2 |
| Figulla, HR | 2 |
| Mirsaeidi, M | 1 |
| Socias, S | 1 |
| Sprenker, C | 1 |
| Caldeira, C | 1 |
| Camporesi, EM | 1 |
| Mangar, D | 1 |
| Adler, C | 1 |
| Pfister, R | 1 |
| Baldus, S | 1 |
| Reuter, H | 1 |
| Guodong, G | 1 |
| Lin, L | 1 |
| Qiang, H | 1 |
| Jinxiao, H | 1 |
| Feilong, H | 1 |
| Bingyan, J | 1 |
| Kun, Y | 1 |
| Cun, L | 1 |
| Qin, Q | 1 |
| Xia, Y | 1 |
| Cao, Y | 1 |
| Davierwala, PM | 1 |
| Leontyev, S | 1 |
| Verevkin, A | 1 |
| Rastan, AJ | 1 |
| Mohr, M | 1 |
| Bakhtiary, F | 1 |
| Misfeld, M | 1 |
| Mohr, FW | 1 |
| Onorati, F | 1 |
| Santarpino, G | 1 |
| Cristodoro, L | 1 |
| Scalas, C | 1 |
| Costanzo, FS | 1 |
| Renzulli, A | 1 |
| Fritzenwanger, M | 1 |
| Lauten, A | 1 |
| Vermeulen, RP | 1 |
| Hoekstra, M | 1 |
| Nijsten, MW | 1 |
| van der Horst, IC | 1 |
| van Pelt, LJ | 1 |
| Jessurun, GA | 1 |
| Jaarsma, T | 1 |
| Zijlstra, F | 1 |
| van den Heuvel, AF | 1 |
| Weil, MH | 3 |
| Tang, W | 1 |
| Dillinger, JG | 1 |
| Deye, N | 1 |
| Logeart, D | 1 |
| Megarbane, B | 1 |
| Sideris, G | 1 |
| Solal, AC | 1 |
| Henry, P | 1 |
| Baud, FJ | 1 |
| Ranocchi, F | 1 |
| Della Monica, PL | 1 |
| Casali, G | 1 |
| Lappa, A | 1 |
| Contento, C | 1 |
| Attaná, P | 1 |
| Lazzeri, C | 1 |
| Chiostri, M | 1 |
| Picariello, C | 1 |
| Gensini, GF | 1 |
| Valente, S | 1 |
| Rimachi, R | 1 |
| Bruzzi de Carvahlo, F | 1 |
| Orellano-Jimenez, C | 1 |
| Cotton, F | 1 |
| De Backer, D | 1 |
| Kopterides, P | 1 |
| Theodorakopoulou, M | 1 |
| Ilias, I | 1 |
| Nikitas, N | 1 |
| Frantzeskaki, F | 1 |
| Vassiliadi, DA | 1 |
| Armaganidis, A | 1 |
| Dimopoulou, I | 1 |
| Nemoto, M | 3 |
| Clec'h, C | 1 |
| Ferriere, F | 1 |
| Karoubi, P | 1 |
| Fosse, JP | 1 |
| Cupa, M | 1 |
| Hoang, P | 1 |
| Cohen, Y | 1 |
| Revelly, JP | 2 |
| Tappy, L | 2 |
| Martinez, A | 1 |
| Bollmann, M | 1 |
| Cayeux, MC | 2 |
| Berger, MM | 2 |
| Chioléro, RL | 2 |
| Geppert, A | 1 |
| Dorninger, A | 1 |
| Delle-Karth, G | 1 |
| Zorn, G | 1 |
| Heinz, G | 1 |
| Huber, K | 1 |
| Reiz, S | 1 |
| Friedman, A | 1 |
| Häggmark, S | 1 |
| Sayeed, MM | 1 |
| Elliott, CG | 1 |
| Morris, AH | 1 |
| Henning, RJ | 1 |
| Weiner, F | 1 |
| Kubát, K | 1 |
| Zboril, M | 1 |
| Wang, TL | 1 |
| Hsu, KL | 1 |
| Chiang, FT | 1 |
| Tseng, CD | 1 |
| Tseng, YZ | 1 |
| Saito, M | 1 |
| Kline, JA | 1 |
| Raymond, RM | 1 |
| Leonova, ED | 1 |
| Williams, TC | 1 |
| Watts, JA | 1 |
| Sezai, A | 2 |
| Shiono, M | 2 |
| Orime, Y | 2 |
| Nakata, K | 2 |
| Hata, M | 2 |
| Yamada, H | 1 |
| Iida, M | 2 |
| Kashiwazaki, S | 2 |
| Kinishita, J | 1 |
| Koujima, T | 2 |
| Sezai, Y | 2 |
| Saitoh, T | 1 |
| Ander, DS | 1 |
| Jaggi, M | 1 |
| Rivers, E | 1 |
| Rady, MY | 1 |
| Levine, TB | 1 |
| Levine, AB | 1 |
| Masura, J | 1 |
| Gryzbowski, M | 1 |
| Kinoshita, J | 1 |
| Furuichi, M | 1 |
| Eda, K | 1 |
| Hirose, H | 1 |
| Yoshino, T | 1 |
| Saitoh, A | 1 |
| Taniguchi, Y | 1 |
| Levy, B | 1 |
| Sadoune, LO | 1 |
| Gelot, AM | 1 |
| Bollaert, PE | 1 |
| Nabet, P | 1 |
| Larcan, A | 1 |
| Janssens, U | 1 |
| Koch, KC | 1 |
| Hanrath, P | 1 |
| Leverve, X | 1 |
| Gersbach, P | 1 |
| Shahryar, S | 1 |
| Carlson, RW | 1 |
| Lauer, B | 1 |
| Hambrecht, R | 1 |
| Boudriot, E | 1 |
| Cohen, HA | 1 |
| Scanu, P | 1 |
| Grollier, G | 1 |
| Guilleman, D | 1 |
| Iselin, M | 1 |
| Bustany, P | 1 |
| Hurpe, JM | 1 |
| Potier, JC | 1 |
| Coraim, FI | 1 |
| Haumer, H | 1 |
| Trubel, W | 1 |
| Simon, P | 1 |
| Rackow, EC | 1 |
| Feola, M | 1 |
| Gonzales, H | 1 |
| Canizaro, PC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Milrinone Versus Dobutamine in a Heterogeneous Population of Critically Ill Patients[NCT03207165] | Phase 4 | 192 participants (Actual) | Interventional | 2017-08-30 | Completed | ||
| Randomized Clinical Study of Intraaortic Balloon Pump Use in Cardiogenic Shock Complicating Acute Myocardial Infarction[NCT00491036] | Phase 4 | 600 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| Prospective Randomized Multicenter Study Comparing Immediate Multivessel Revascularization by PCI Versus Culprit Lesion PCI With Staged Non-culprit Lesion Revascularization in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock[NCT01927549] | Phase 4 | 706 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
| Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children[NCT04420468] | 30 participants (Anticipated) | Observational | 2020-06-10 | Recruiting | |||
| Exploratory Study. Endothelial Function and Vascular Biomarkers: Predictive Indicators of the Progression From Gestational Hypertension to Preeclampsia?[NCT04520048] | 110 participants (Anticipated) | Interventional | 2023-08-24 | Recruiting | |||
| Effects of Advanced Mechanical Circulatory Support in Patients With ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock. The Danish Cardiogenic Shock Trial[NCT01633502] | 360 participants (Actual) | Interventional | 2012-12-31 | Active, not recruiting | |||
| Transfusion Requirements After Cardiac Surgery: a Randomized Controlled Clinical Trial (TRACS STUDY)[NCT01021631] | Phase 3 | 500 participants (Anticipated) | Interventional | 2009-02-28 | Recruiting | ||
| A Feasibility Study to Consider the Relationship Between Markers of Red Cell Damage, Inflammation and the Recovery Process of Newborns Requiring Extracorporeal Membrane Oxygenation (ECMO) for Persistent Pulmonary Hypertension of the Newborn (PPHN): Mi-ECM[NCT02940327] | 24 participants (Actual) | Observational | 2016-02-19 | Completed | |||
| Peripheral Perfusion Versus Lactate Targeted Fluid Resuscitation in Septic Shock: ANDROMEDA-SHOCK PHYSIOLOGY STUDY[NCT03762005] | 46 participants (Anticipated) | Interventional | 2018-06-01 | Recruiting | |||
| Lactate Clearance and Mortality in Patients With Severe Sepsis and Septic Shock: Comparison by Hepatic Dysfunction[NCT01709565] | 245 participants (Anticipated) | Observational | 2012-07-31 | Recruiting | |||
| "Influence of High Vitamin C Dose on Lactate During Extracorporeal Circulation for Heart Surgery and During the 24 Hours Thereafter. (Double Blind Prospective Randomised Study)"[NCT04046861] | 200 participants (Anticipated) | Interventional | 2023-02-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Clinical and biochemical markers of organ failure (NCT02940327)
Timeframe: 24 hours after ECMO is discontinued
| Intervention | ml (Mean) |
|---|---|
| 7+ Days | 289.6 |
| <7 Days | 479.2 |
Change of markers of platelet and leukocyte activation in arterial blood and analysed by flow cytometry. (NCT02940327)
Timeframe: 12 hours after ECMO commencement
| Intervention | percentage change (Mean) |
|---|---|
| 7+ Days | 1.5 |
| <7 Days | 0.84 |
Change of markers of platelet and leukocyte activation in arterial blood and analysed by flow cytometry. (NCT02940327)
Timeframe: 24 hours after ECMO commencement
| Intervention | percentage change (Mean) |
|---|---|
| 7+ Days | 3.02 |
| <7 Days | 0.38 |
Change of markers of platelet and leukocyte activation in arterial blood and analysed by flow cytometry. (NCT02940327)
Timeframe: 24 hours after ECMO decannulation
| Intervention | percentage change (Mean) |
|---|---|
| 7+ Days | 1.01 |
| <7 Days | 0.40 |
Change of markers of platelet and leukocyte activation in arterial blood and analysed by flow cytometry. (NCT02940327)
Timeframe: 48 hours after ECMO commencement
| Intervention | percentage change (Mean) |
|---|---|
| 7+ Days | 0.29 |
| <7 Days | 0.27 |
Change of markers of platelet and leukocyte activation in arterial blood and analysed by flow cytometry. (NCT02940327)
Timeframe: 72 hours after ECMO commencement
| Intervention | percentage change (Mean) |
|---|---|
| 7+ Days | 0.72 |
| <7 Days | 0.59 |
Change of markers of platelet and leukocyte activation in arterial blood and analysed by flow cytometry. (NCT02940327)
Timeframe: 12 hours after ECMO commencement
| Intervention | percent change (Mean) |
|---|---|
| 7+ Days | 1.90 |
| <7 Days | 1.13 |
Change of markers of platelet and leukocyte activation in arterial blood and analysed by flow cytometry. (NCT02940327)
Timeframe: 24 hours after decannulation
| Intervention | percentage change (Mean) |
|---|---|
| 7+ Days | 1.56 |
| <7 Days | 0.6 |
Change of markers of platelet and leukocyte activation in arterial blood and analysed by flow cytometry. (NCT02940327)
Timeframe: 24 hours after ECMO commencement
| Intervention | percentage change (Mean) |
|---|---|
| 7+ Days | 3.11 |
| <7 Days | 0.64 |
Change of markers of platelet and leukocyte activation in arterial blood and analysed by flow cytometry. (NCT02940327)
Timeframe: 48 hours after ECMO commencement
| Intervention | percentage change (Mean) |
|---|---|
| 7+ Days | 0.73 |
| <7 Days | 0.4 |
Change of markers of platelet and leukocyte activation in arterial blood and analysed by flow cytometry. (NCT02940327)
Timeframe: 72 hours after ECMO commencement
| Intervention | percentage change (Mean) |
|---|---|
| 7+ Days | 1.55 |
| <7 Days | 0.93 |
Change of markers of platelet and leukocyte activation in arterial blood and analysed by flow cytometry. (NCT02940327)
Timeframe: 12 hours after ECMO commencement
| Intervention | percentage change (Mean) |
|---|---|
| 7+ Days | 8.7 |
| <7 Days | 4.65 |
Change of markers of platelet and leukocyte activation in arterial blood and analysed by flow cytometry. (NCT02940327)
Timeframe: 24 hours after decannulation
| Intervention | percentage change (Mean) |
|---|---|
| 7+ Days | 3.2 |
| <7 Days | 2.27 |
Change of markers of platelet and leukocyte activation in arterial blood and analysed by flow cytometry. (NCT02940327)
Timeframe: 24 hours after ECMO commencement
| Intervention | percentage change (Mean) |
|---|---|
| 7+ Days | 7.34 |
| <7 Days | 1.89 |
Change of markers of platelet and leukocyte activation in arterial blood and analysed by flow cytometry. (NCT02940327)
Timeframe: 48 hours after ECMO commencement
| Intervention | percentage change (Mean) |
|---|---|
| 7+ Days | 3.26 |
| <7 Days | 0.92 |
Change of markers of platelet and leukocyte activation in arterial blood and analysed by flow cytometry. (NCT02940327)
Timeframe: 72 hours after ECMO commencement
| Intervention | percentage change (Mean) |
|---|---|
| 7+ Days | 3.31 |
| <7 Days | 1.9 |
Clinical and biochemical markers of organ failure (NCT02940327)
Timeframe: 12 hours after ECMO commencement
| Intervention | g/L (Mean) |
|---|---|
| 7+ Days | 109.64 |
| <7 Days | 112.07 |
Clinical and biochemical markers of organ failure (NCT02940327)
Timeframe: 24 hours after decannulation
| Intervention | g/L (Mean) |
|---|---|
| 7+ Days | 109.25 |
| <7 Days | 110.23 |
Clinical and biochemical markers of organ failure (NCT02940327)
Timeframe: 24 hours after ECMO commencement
| Intervention | g/L (Mean) |
|---|---|
| 7+ Days | 114.30 |
| <7 Days | 109.43 |
Clinical and biochemical markers of organ failure (NCT02940327)
Timeframe: 48 hours after ECMO commencement
| Intervention | g/L (Mean) |
|---|---|
| 7+ Days | 112.56 |
| <7 Days | 113.08 |
Clinical and biochemical markers of organ failure (NCT02940327)
Timeframe: 72 hours after ECMO commencement
| Intervention | g/L (Mean) |
|---|---|
| 7+ Days | 112.90 |
| <7 Days | 109.89 |
Clinical and biochemical markers of organ failure (NCT02940327)
Timeframe: baseline
| Intervention | g/L (Mean) |
|---|---|
| 7+ Days | 151.5 |
| <7 Days | 145.4 |
Clinical and biochemical markers of organ failure (NCT02940327)
Timeframe: > 7 days or did not survive to discharge
| Intervention | hours (Median) |
|---|---|
| 7+ Days | 292 |
| <7 Days | 80 |
Clinical and biochemical markers of organ failure (NCT02940327)
Timeframe: 12 hours after ECMO commencement
| Intervention | ng/ml (Mean) |
|---|---|
| 7+ Days | 7.89 |
| <7 Days | 6.96 |
Clinical and biochemical markers of organ failure (NCT02940327)
Timeframe: 24 hours after decannulation
| Intervention | ng/ml (Mean) |
|---|---|
| 7+ Days | 9.54 |
| <7 Days | 7.44 |
Clinical and biochemical markers of organ failure (NCT02940327)
Timeframe: 24 hours after ECMO commencement
| Intervention | ng/ml (Mean) |
|---|---|
| 7+ Days | 3.71 |
| <7 Days | 3.11 |
Clinical and biochemical markers of organ failure (NCT02940327)
Timeframe: 48 hours after ECMO commencement
| Intervention | ng/ml (Mean) |
|---|---|
| 7+ Days | 2.13 |
| <7 Days | 1.81 |
Clinical and biochemical markers of organ failure (NCT02940327)
Timeframe: 72 hours after ECMO commencement
| Intervention | ng/ml (Mean) |
|---|---|
| 7+ Days | 5.51 |
| <7 Days | 5.88 |
Clinical and biochemical markers of organ failure (NCT02940327)
Timeframe: 24 hours after ECMO is discontinued
| Intervention | Participants (Count of Participants) |
|---|---|
| 7+ Days | 10 |
| <7 Days | 10 |
Clinical and biochemical markers of organ failure (NCT02940327)
Timeframe: >7 days or did not survive to discharge
| Intervention | participants (Number) |
|---|---|
| 7+ Days | 3 |
| <7 Days | 0 |
10 reviews available for lactic acid and Shock, Cardiogenic
| Article | Year |
|---|---|
Lactate Clearance Is Associated With Improved Survival in Cardiogenic Shock: A Systematic Review and Meta-Analysis of Prognostic Factor Studies.
Topics: Heart Failure; Humans; Lactic Acid; Prognosis; Prospective Studies; Retrospective Studies; Shock, Ca | 2021 |
Identifying cardiogenic shock in the emergency department.
Topics: Acidosis, Lactic; Bradycardia; Confusion; Early Diagnosis; Echocardiography; Edema; Electrocardiogra | 2020 |
Practical Management of ECPELLA.
Topics: Acidosis; Assisted Circulation; Combined Modality Therapy; Extracorporeal Membrane Oxygenation; Femo | 2020 |
Quantitative Assessment of Blood Lactate in Shock: Measure of Hypoxia or Beneficial Energy Source.
Topics: Animals; Critical Illness; Disease Models, Animal; Dogs; Humans; Hypoxia; Lactic Acid; Liver; Models | 2020 |
Lactate in cardiogenic shock - current understanding and clinical implications.
Topics: Animals; Humans; Lactic Acid; Shock, Cardiogenic | 2018 |
Lactate and other biomarkers as treatment target in cardiogenic shock.
Topics: Biomarkers; Humans; Lactic Acid; Prognosis; Shock, Cardiogenic | 2019 |
Nonischemic Causes of Cardiogenic Shock.
Topics: Algorithms; Anti-Arrhythmia Agents; Cardiotonic Agents; Catheterization; Echocardiography; Electroca | 2019 |
[Treatment of cardiogenic shock: what is proven?].
Topics: Combined Modality Therapy; Early Medical Intervention; Evidence-Based Medicine; Hospital Mortality; | 2013 |
[Evaluation of microcirculation in cardiogenic shock].
Topics: Blood Flow Velocity; Cardiotonic Agents; Combined Modality Therapy; Echocardiography; Equipment Desi | 2010 |
[Clinical symptoms of cardiogenic shock and important points in evaluating the severity].
Topics: Hemodynamics; Humans; Lactic Acid; Oxygen Consumption; Severity of Illness Index; Shock, Cardiogenic | 1996 |
6 trials available for lactic acid and Shock, Cardiogenic
| Article | Year |
|---|---|
Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI Trial.
Topics: Dobutamine; Hospital Mortality; Humans; Lactic Acid; Milrinone; Shock, Cardiogenic | 2022 |
Lactate is a Prognostic Factor in Patients Admitted With Suspected ST-Elevation Myocardial Infarction.
Topics: Aged; Blood Pressure; Disease-Free Survival; Female; Humans; Lactic Acid; Male; Middle Aged; Shock, | 2019 |
Rationale and design of DanGer shock: Danish-German cardiogenic shock trial.
Topics: Aged; Blood Pressure; Cause of Death; Female; Guideline Adherence; Heart-Assist Devices; Humans; Lac | 2019 |
High lactate levels are predictors of major complications after cardiac surgery.
Topics: Acute Kidney Injury; Age Factors; Aged; Biomarkers; Brazil; Cardiac Surgical Procedures; Chi-Square | 2013 |
Intraaortic balloon counterpulsation and microcirculation in cardiogenic shock complicating myocardial infarction: an IABP-SHOCK II substudy.
Topics: Aged; Aged, 80 and over; Biomarkers; Capillaries; Female; Germany; Humans; Intra-Aortic Balloon Pump | 2015 |
Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Assisted Circulation; Blood Pressure | 2001 |
87 other studies available for lactic acid and Shock, Cardiogenic
| Article | Year |
|---|---|
Venoarterial Extracorporeal Membrane Oxygenation in Severe Drug Intoxication: A Retrospective Comparison of Survivors and Nonsurvivors.
Topics: Extracorporeal Membrane Oxygenation; Humans; Lactic Acid; Retrospective Studies; Shock, Cardiogenic; | 2022 |
Lactate levels as a prognostic predict in cardiogenic shock under venoarterial extracorporeal membrane oxygenation support.
Topics: Extracorporeal Membrane Oxygenation; Humans; Lactic Acid; Prognosis; Retrospective Studies; Shock, C | 2022 |
Using Base Excess, Albumin, Lactate, and Renal Function to Predict 30-Day Mortality in Patients Requiring Impella Monotherapy for Left-Sided Mechanical Circulatory Support: The BALLAR Score.
Topics: Albumins; Heart-Assist Devices; Humans; Kidney; Lactic Acid; Retrospective Studies; Shock, Cardiogen | 2022 |
Predicting mortality in nonsurgical patients before cannulation for veno-arterial extracorporeal life support: Development and validation of the LACT-8 score.
Topics: Catheterization; Hospital Mortality; Humans; Lactic Acid; Retrospective Studies; Shock, Cardiogenic; | 2022 |
Association Between the Acidemia, Lactic Acidosis, and Shock Severity With Outcomes in Patients With Cardiogenic Shock.
Topics: Acidosis; Acidosis, Lactic; Aged; Cohort Studies; Female; Humans; Lactic Acid; Male; Shock; Shock, C | 2022 |
Clinical outcome and risk factors for acute fulminant myocarditis supported by venoarterial extracorporeal membrane oxygenation: An analysis of nationwide CSECLS database in China.
Topics: Adult; Extracorporeal Membrane Oxygenation; Heart Arrest; Humans; Lactic Acid; Male; Myocarditis; Re | 2023 |
Outcomes of hyperlactatemia on admission in critically ill patients with acute myocardial infarction: A retrospective study from MIMIC-IV.
Topics: Critical Illness; Heart Failure; Humans; Hyperlactatemia; Lactic Acid; Myocardial Infarction; Retros | 2022 |
Time course, factors related to, and prognostic impact of venoarterial extracorporeal membrane flow in cardiogenic shock.
Topics: Female; Hospital Mortality; Humans; Lactic Acid; Male; Middle Aged; Pneumonia, Ventilator-Associated | 2023 |
Topics: Bronchiolitis; Cardiac Surgical Procedures; Disease Progression; Extracorporeal Membrane Oxygenation | 2023 |
Short-Term Lactate Kinetics in Patients With Cardiogenic Shock.
Topics: Heart Failure; Heart-Assist Devices; Humans; Kinetics; Lactic Acid; Shock, Cardiogenic | 2023 |
Reply to the letter "Understanding lactate and its clearance during extracorporeal membrane oxygenation for supporting refractory cardiogenic shock patients".
Topics: Extracorporeal Membrane Oxygenation; Hospital Mortality; Humans; Lactic Acid; Retrospective Studies; | 2023 |
Understanding lactate and its clearance during extracorporeal membrane oxygenation for supporting refractory cardiogenic shock patients.
Topics: Extracorporeal Membrane Oxygenation; Humans; Lactic Acid; Retrospective Studies; Shock, Cardiogenic | 2023 |
Early Utilization of Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock: The National Cardiogenic Shock Initiative.
Topics: Aged; Female; Heart-Assist Devices; Humans; Lactic Acid; Male; Middle Aged; Myocardial Infarction; S | 2023 |
Shock Severity and Hospital Mortality In Out of Hospital Cardiac Arrest Patients Treated With Targeted Temperature Management.
Topics: Aged; Arterial Pressure; Female; Hospital Mortality; Humans; Hypothermia, Induced; Lactic Acid; Logi | 2021 |
Arterial Lactate in Cardiogenic Shock: Prognostic Value of Clearance Versus Single Values.
Topics: Humans; Intra-Aortic Balloon Pumping; Lactic Acid; Prognosis; Shock, Cardiogenic; Treatment Outcome | 2020 |
Arterial Lactate Assessment in Cardiogenic Shock: It Is High Time to Beat the Clock.
Topics: Humans; Intra-Aortic Balloon Pumping; Lactic Acid; Prognosis; Shock, Cardiogenic; Treatment Outcome | 2020 |
Association between serum lactate levels and mortality in patients with cardiogenic shock receiving mechanical circulatory support: a multicenter retrospective cohort study.
Topics: Adult; Biomarkers; Brazil; Extracorporeal Membrane Oxygenation; Female; Heart-Assist Devices; Humans | 2020 |
Early Recognition and Intervention Are Critical for Patients in Cardiogenic Shock.
Topics: Humans; Intra-Aortic Balloon Pumping; Lactic Acid; Prognosis; Shock, Cardiogenic; Treatment Outcome | 2021 |
Reply: Early Recognition and Intervention Are Critical for Patients in Cardiogenic Shock.
Topics: Humans; Intra-Aortic Balloon Pumping; Lactic Acid; Percutaneous Coronary Intervention; Prognosis; Sh | 2021 |
Defining Shock and Preshock for Mortality Risk Stratification in Cardiac Intensive Care Unit Patients.
Topics: Aged; Aged, 80 and over; Arterial Pressure; Blood Pressure; Coronary Care Units; Creatinine; Female; | 2021 |
Outcomes from adult veno-arterial extracorporeal membrane oxygenation in a cardiovascular disease center from 2009 to 2019.
Topics: Adult; Cardiovascular Diseases; Extracorporeal Membrane Oxygenation; Female; Hospital Mortality; Hum | 2022 |
Impella use in real-world cardiogenic shock patients: Sobering outcomes.
Topics: Adult; Aged; Aged, 80 and over; Critical Care; Critical Illness; Female; Heart Arrest; Heart-Assist | 2021 |
The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction.
Topics: Cystatin C; Humans; Interleukin-6; Intra-Aortic Balloon Pumping; Lactic Acid; Myocardial Infarction; | 2021 |
The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction.
Topics: Cystatin C; Humans; Interleukin-6; Intra-Aortic Balloon Pumping; Lactic Acid; Myocardial Infarction; | 2021 |
The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction.
Topics: Cystatin C; Humans; Interleukin-6; Intra-Aortic Balloon Pumping; Lactic Acid; Myocardial Infarction; | 2021 |
The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction.
Topics: Cystatin C; Humans; Interleukin-6; Intra-Aortic Balloon Pumping; Lactic Acid; Myocardial Infarction; | 2021 |
Survival on Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock: Which Lactate Is Most Useful?
Topics: Extracorporeal Membrane Oxygenation; Hospital Mortality; Humans; Lactic Acid; Retrospective Studies; | 2022 |
Laboratory Markers of Acidosis and Mortality in Cardiogenic Shock: Developing a Definition of Hemometabolic Shock.
Topics: Acid-Base Equilibrium; Acidosis; Aged; Biomarkers; Female; Hospital Mortality; Humans; Intensive Car | 2022 |
Endothelial Dysfunction as a Component of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children With Shock.
Topics: Adrenal Cortex Hormones; Angiopoietin-2; Biomarkers; C-Reactive Protein; Cardiotonic Agents; Child; | 2021 |
Endothelial Dysfunction as a Component of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children With Shock.
Topics: Adrenal Cortex Hormones; Angiopoietin-2; Biomarkers; C-Reactive Protein; Cardiotonic Agents; Child; | 2021 |
Endothelial Dysfunction as a Component of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children With Shock.
Topics: Adrenal Cortex Hormones; Angiopoietin-2; Biomarkers; C-Reactive Protein; Cardiotonic Agents; Child; | 2021 |
Endothelial Dysfunction as a Component of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children With Shock.
Topics: Adrenal Cortex Hormones; Angiopoietin-2; Biomarkers; C-Reactive Protein; Cardiotonic Agents; Child; | 2021 |
Outcome in Elderly Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction.
Topics: Age Factors; Aged; Aged, 80 and over; Cohort Studies; Denmark; Female; Hospital Mortality; Hospitali | 2022 |
Lactate and lactate clearance as valuable tool to evaluate ECMO therapy in cardiogenic shock.
Topics: Adult; Biomarkers; Extracorporeal Membrane Oxygenation; Female; Humans; Lactic Acid; Male; Middle Ag | 2017 |
Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Coronary Angiography; Female; Heart Failure; Humans; Kap | 2018 |
Predicting Survival in Patients Treated With Extracorporeal Membrane Oxygenation After Myocardial Infarction.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Body Mass Index; Extracorporeal Membrane Oxygenation; F | 2018 |
Does lactate clearance prognosticates outcomes in ECMO therapy: a retrospective observational study.
Topics: Adult; Aged; Extracorporeal Membrane Oxygenation; Female; Humans; Lactic Acid; Male; Middle Aged; Pr | 2018 |
The role of perioperative cardiorespiratory support in post infarction ventricular septal rupture-related cardiogenic shock.
Topics: Aged; Aged, 80 and over; Alanine Transaminase; Case-Control Studies; Creatinine; Extracorporeal Memb | 2020 |
Blood Lactate as a Reliable Marker for Mortality of Pediatric Refractory Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation.
Topics: Area Under Curve; Biomarkers; Child; Child, Preschool; Cohort Studies; Extracorporeal Membrane Oxyge | 2019 |
Arterial lactate before initiation of venoarterial extracorporeal membrane oxygenation for postcardiotomy shock improves postimplant outcome prediction.
Topics: Extracorporeal Membrane Oxygenation; Humans; Lactic Acid; Shock, Cardiogenic | 2019 |
Lactate monitoring for risk stratification in postcardiotomy patients with extracorporeal membrane oxygenator support.
Topics: Extracorporeal Membrane Oxygenation; Humans; Lactic Acid; Oxygenators, Membrane; Risk Assessment; Sh | 2019 |
Outcomes following venoarterial extracorporeal membrane oxygenation in children with refractory cardiogenic disease.
Topics: Child; Child, Preschool; Extracorporeal Membrane Oxygenation; Female; Heart Defects, Congenital; Hos | 2019 |
Serum Lactate and A Relative Change in Lactate as Predictors of Mortality in Patients With Cardiogenic Shock - Results from the Cardshock Study.
Topics: Adult; Aged; Aged, 80 and over; Female; Hemodynamics; Humans; Lactic Acid; Male; Middle Aged; Multiv | 2020 |
Real-world clinical experience with the percutaneous extracorporeal life support system: Results from the German Lifebridge
Topics: Aged; Cardiopulmonary Resuscitation; Cohort Studies; Critical Illness; Extracorporeal Membrane Oxyge | 2020 |
Predictors of Mortality and Outcomes of Acute Severe Cardiogenic Shock Treated with the Impella Device.
Topics: Aged; Assisted Circulation; Carbon Dioxide; Cardiotonic Agents; Female; Heart Arrest; Heart-Assist D | 2019 |
Outcomes of early versus delayed initiation of extracorporeal life support in cardiac surgery.
Topics: Adult; Aged; Cardiac Surgical Procedures; Extracorporeal Membrane Oxygenation; Female; Humans; Lacti | 2019 |
Low-dose vasopressin improves cardiac function in newborn piglets with acute hypoxia-reoxygenation.
Topics: Animals; Animals, Newborn; Asphyxia Neonatorum; Cardiac Output; Dobutamine; Glutathione; Heart Ventr | 2013 |
Percutaneous extracorporeal life support for patients in therapy refractory cardiogenic shock: initial results of an interdisciplinary team.
Topics: Acute Coronary Syndrome; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Cardiomyopathies; E | 2014 |
Clinical impact of intra-aortic balloon pump during extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock.
Topics: Aged; Combined Modality Therapy; Extracorporeal Circulation; Female; Hospital Mortality; Humans; Int | 2014 |
Extracorporeal membrane oxygenation support in refractory cardiogenic shock: treatment strategies and analysis of risk factors.
Topics: Adult; Aged; Aged, 80 and over; Blood Transfusion; Creatine Kinase; Equipment Design; Extracorporeal | 2014 |
["Bridge to recovery"- implantation of an Impella® CP in infarct-related cardiogenic shock].
Topics: Adult; Angioplasty, Balloon, Coronary; Cardiopulmonary Resuscitation; Coronary Angiography; Critical | 2015 |
[Extracorporeal membrane oxygenation for the treatment of refractory cardiogenic shock in adults: strategies, results, and predictors of mortality].
Topics: Adult; Aged; Biomarkers; Blood Transfusion; Creatine Kinase; Extracorporeal Membrane Oxygenation; Fe | 2014 |
[Veno-arterial extracorporeal membrane oxygenation system: "leave the chest closed!"].
Topics: Extracorporeal Membrane Oxygenation; Female; Heart Failure; Humans; Lactic Acid; Male; Shock, Cardio | 2014 |
Prognostic implication of out-of-hospital cardiac arrest in patients with cardiogenic shock and acute myocardial infarction.
Topics: Age Factors; Aged; Comorbidity; Denmark; Female; Humans; Lactic Acid; Male; Middle Aged; Myocardial | 2015 |
First-in-man analysis of the i-cor assist device in patients with cardiogenic shock.
Topics: Blood Transfusion; Catecholamines; Extracorporeal Membrane Oxygenation; Female; Germany; Glomerular | 2015 |
The early dynamic behavior of lactate is linked to mortality in postcardiotomy patients with extracorporeal membrane oxygenation support: A retrospective observational study.
Topics: Adult; Age Factors; Aged; Biomarkers; Cardiac Surgical Procedures; Chi-Square Distribution; Extracor | 2015 |
Temporary mechanical circulatory support for postcardiotomy shock: Don't come late to the party.
Topics: Cardiac Surgical Procedures; Extracorporeal Membrane Oxygenation; Female; Humans; Lactic Acid; Male; | 2015 |
The use of Impella 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction.
Topics: Blood Circulation; Cardiotonic Agents; Female; France; Heart-Assist Devices; Hemodynamics; Humans; I | 2015 |
Plasma Free Hemoglobin Is an Independent Predictor of Mortality among Patients on Extracorporeal Membrane Oxygenation Support.
Topics: Aged; Biomarkers; Blood Transfusion; Cardiomyopathies; Extracorporeal Membrane Oxygenation; Female; | 2015 |
[Mild therapeutic hypothermia in cardiogenic shock : Retrospective analysis of 80 patients with preclinical cardiac arrest due to cardiac causes].
Topics: Comorbidity; Creatinine; Female; Humans; Hypothermia, Induced; Lactic Acid; Male; Middle Aged; Neuro | 2017 |
[Outcome of extracorporeal membrane oxygenation support for adult patients in Fuwai Hospital during the last 10 years: treatment strategy and risk factors].
Topics: Adult; Cardiopulmonary Resuscitation; Extracorporeal Membrane Oxygenation; Female; Gastrointestinal | 2015 |
Clinical study of a new Modified Early Warning System scoring system for rapidly evaluating shock in adults.
Topics: Adult; Aged; APACHE; Area Under Curve; Arterial Pressure; Biomedical Research; Early Diagnosis; Emer | 2017 |
Temporal Trends in Predictors of Early and Late Mortality After Emergency Coronary Artery Bypass Grafting for Cardiogenic Shock Complicating Acute Myocardial Infarction.
Topics: Age Factors; Aged; Coronary Artery Bypass; Disease-Free Survival; Extracorporeal Membrane Oxygenatio | 2016 |
Continuous coronary sinus perfusion reverses ongoing myocardial damage in acute ischemia.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Cardiopulmonary Bypass; Cardiotonic Agents; Coronary Arte | 2009 |
Clinical correlates of arterial lactate levels in patients with ST-segment elevation myocardial infarction at admission: a descriptive study.
Topics: Aged; Biomarkers; Female; Femoral Artery; Humans; Lactic Acid; Male; Middle Aged; Myocardial Infarct | 2010 |
Clinical correlates of arterial lactate levels in STEMI patients.
Topics: Female; Humans; Lactic Acid; Male; Myocardial Infarction; Patient Admission; Shock, Cardiogenic | 2011 |
Prognostic value of plasma B-type natriuretic peptide in patients with severe cardiotoxic drug poisoning.
Topics: Adult; Biomarkers; Cardiotoxins; Female; France; Humans; Intensive Care Units; Lactic Acid; Male; Mi | 2011 |
Peripheral extracorporeal membrane oxygenation system as salvage treatment of patients with refractory cardiogenic shock: preliminary outcome evaluation.
Topics: Adult; Aged; Aged, 80 and over; Blood Transfusion; Creatine Kinase, MB Form; Extracorporeal Membrane | 2012 |
Lactate clearance in cardiogenic shock following ST elevation myocardial infarction: a pilot study.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Female; Follow-Up Studies; Humans; Kaplan-M | 2012 |
Lactate/pyruvate ratio as a marker of tissue hypoxia in circulatory and septic shock.
Topics: Aerobiosis; Aged; APACHE; Biomarkers; Female; Humans; Hypoxia; Lactic Acid; Male; Middle Aged; Pyruv | 2012 |
Interrelationship between blood and tissue lactate in a general intensive care unit: a subcutaneous adipose tissue microdialysis study on 162 critically ill patients.
Topics: Adipose Tissue; Aged; Extracellular Fluid; Female; Health Status Indicators; Humans; Intensive Care | 2012 |
Experimental evaluation of the influence of complete artificial circulation on renal circulation and tissue metabolism -comparative study of pulsatile vs nonpulsatile circulation.
Topics: Analysis of Variance; Animals; beta 2-Microglobulin; Blood Urea Nitrogen; Creatinine; Disease Models | 2003 |
Diagnostic and prognostic value of procalcitonin in patients with septic shock.
Topics: Adult; Aged; APACHE; Bacterial Infections; Biomarkers; C-Reactive Protein; Calcitonin; Calcitonin Ge | 2004 |
Lactate and glucose metabolism in severe sepsis and cardiogenic shock.
Topics: Adult; Case-Control Studies; Glucose; Humans; Lactic Acid; Oxidation-Reduction; Prospective Studies; | 2005 |
Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction.
Topics: Acute Kidney Injury; Aged; Biomarkers; Female; Humans; Intensive Care Units; Interleukin-6; Lactic A | 2006 |
Hemodynamic and cardiometabolic effects of prenalterol in patients with acute myocardial infarction and shock.
Topics: Adrenergic beta-Agonists; Aged; Blood Pressure; Cardiac Output; Humans; Lactates; Lactic Acid; Male; | 1981 |
Pulmonary cellular dysfunction in endotoxin shock: metabolic and transport derangements.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Adenylyl Cyclases; Animals; Biological Transport; Capil | 1982 |
Respiratory muscle contribution to lactic acidosis in low cardiac output--do the methods limit the conclusions?
Topics: Acidosis; Animals; Humans; Lactates; Lactic Acid; Respiration, Artificial; Shock, Cardiogenic | 1983 |
Blood lactate as prognostic indicator of survival in patients with acute myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Rate; Humans; Lactates; Lactic Acid; Male | 1982 |
[Determination of serum lactic acid and the acid-base equilibrium in carbon monoxide poisoning].
Topics: Accidents, Home; Acid-Base Equilibrium; Adolescent; Carbon Monoxide Poisoning; Female; Humans; Lacta | 1995 |
Anaerobic metabolism in patients undergoing intra-aortic balloon counterpulsation for cardiogenic shock.
Topics: Adult; Aged; Anaerobiosis; Female; Hemodynamics; Humans; Intra-Aortic Balloon Pumping; Lactates; Lac | 1995 |
Insulin improves heart function and metabolism during non-ischemic cardiogenic shock in awake canines.
Topics: Animals; Calcium Channel Blockers; Dogs; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; | 1997 |
Renal circulation and cellular metabolism during left ventricular assisted circulation: comparison study of pulsatile and nonpulsatile assists.
Topics: Animals; beta 2-Microglobulin; Blood Pressure; Blood Urea Nitrogen; Creatinine; Disease Models, Anim | 1997 |
Undetected cardiogenic shock in patients with congestive heart failure presenting to the emergency department.
Topics: Aged; Case-Control Studies; Emergencies; Emergency Treatment; Heart Failure; Humans; Lactic Acid; Mi | 1998 |
Major organ function under mechanical support: comparative studies of pulsatile and nonpulsatile circulation.
Topics: Animals; Blood Circulation; Cerebrovascular Circulation; Heart-Assist Devices; Hemodynamics; Ketone | 1999 |
Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock.
Topics: Acidosis, Lactic; Adult; Aged; Aged, 80 and over; Case-Control Studies; Catecholamines; Female; Hemo | 2000 |
Gastric tonometry in patients with cardiogenic shock and intra-aortic balloon counterpulsation.
Topics: Aged; Blood Gas Analysis; Carbon Dioxide; Discriminant Analysis; Female; Gastric Mucosa; Hemodynamic | 2000 |
Effects of cardiogenic shock on lactate and glucose metabolism after heart surgery.
Topics: Acidosis, Lactic; Adult; Aged; Bilirubin; Cardiac Surgical Procedures; Case-Control Studies; Female; | 2000 |
Type A lactic acidosis in cardiogenic shock.
Topics: Acidosis, Lactic; Anaerobiosis; Humans; Lactic Acid; Metabolic Clearance Rate; Oxygen Consumption; S | 2000 |
Malignant ventricular tachycardia during propafenone treatment in a child with junctional automatic tachycardia: effectiveness of intravenous molar sodium lactate.
Topics: Atrioventricular Node; Bundle-Branch Block; Child, Preschool; Electrocardiography; Female; Humans; L | 1991 |
Regulation of acid-base state with hemofiltration in circulatory shock in patients after open heart surgery.
Topics: Acid-Base Imbalance; Ammonia; Bicarbonates; Cardiac Surgical Procedures; Glutamine; Hemofiltration; | 1991 |
Physiology of blood flow and oxygen utilization by peripheral tissue in circulatory shock.
Topics: Blood Flow Velocity; Heart Arrest; Hemodynamics; Humans; Lactates; Lactic Acid; Oxygen Consumption; | 1990 |
Vasoactive parathyroid hormone in the treatment of acute ischemic left ventricular failure and the prevention of cardiogenic shock.
Topics: Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Dogs; Female; Hemodynamics; Lactate | 1985 |